TapewireFind a company

person · Reporting owner

Coen Steven P.

Disclosed activity across 1 company

Tapewire entity
19781
SEC CIK
0001977441

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Ginkgo Bioworks Holdings, Inc.DNA · Entity 5530See remarksOctober 05, 2026October 07, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Ginkgo Bioworks Holdings, Inc.

Report date October 05, 2026 · Filed October 07, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect49,448 Reported balance After 2026-10-05 transaction · row 1
1 source row

Row 1 · 2026-10-05 · Sale · Disposed 2,403 · Balance 49,448

F1: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934

Filing footnotes · ownership attribution and instrument terms

F1: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 01, 2024 Filed Nov 6, 2024 21:29 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 587 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-026591 · form4.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,633

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
October 04, 2024 Filed Oct 8, 2024 20:27 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 306 $8.35 $2,555.41
Disclosure

SEC source: 0001127602-24-025334 · form4.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,046

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
October 03, 2024 Filed Oct 8, 2024 20:27 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 156 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-025334 · form4.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,407

Underlying: Class A Common Stock · 156 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
October 03, 2024 Filed Oct 8, 2024 20:27 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 587 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-025334 · form4.xml · derivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,210

Underlying: Class A Common Stock · 587 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document
October 03, 2024 Filed Oct 8, 2024 20:27 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 156 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-025334 · form4.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,352

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
October 03, 2024 Filed Oct 8, 2024 20:27 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 587 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-025334 · form4.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,196

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
September 12, 2024 Filed Sep 16, 2024 20:28 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 316 $6.17 $1,950.35
Disclosure

SEC source: 0001127602-24-024002 · form4.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,609

F3 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024.

Read SEC document
September 11, 2024 Filed Sep 16, 2024 20:28 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 156 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-024002 · form4.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,563

Underlying: Class A Common Stock · 156 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F5 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F5 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024.

Read SEC document
September 11, 2024 Filed Sep 16, 2024 20:28 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 587 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-024002 · form4.xml · derivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,797

Underlying: Class A Common Stock · 587 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024.

Read SEC document
September 11, 2024 Filed Sep 16, 2024 20:28 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 156 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-024002 · form4.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,925

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024.

Read SEC document
September 11, 2024 Filed Sep 16, 2024 20:28 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 587 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-024002 · form4.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,769

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024.

Read SEC document
August 02, 2024 Filed Aug 6, 2024 20:39 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 17,486 $0.29 $5,018.48
Disclosure

SEC source: 0001127602-24-021720 · form4.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,318

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
August 01, 2024 Filed Aug 6, 2024 20:39 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 6,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-021720 · form4.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 268,751

Underlying: Class A Common Stock · 6,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
August 01, 2024 Filed Aug 6, 2024 20:39 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 23,496 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-021720 · form4.xml · derivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 775,377

Underlying: Class A Common Stock · 23,496 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document
August 01, 2024 Filed Aug 6, 2024 20:39 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 6,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-021720 · form4.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,804

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
August 01, 2024 Filed Aug 6, 2024 20:39 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 23,496 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-021720 · form4.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,554

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
July 02, 2024 Filed Jul 5, 2024 20:02 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 13,520 $0.33 $4,407.52
Disclosure

SEC source: 0001127602-24-020165 · form4.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,058

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
July 01, 2024 Filed Jul 5, 2024 20:02 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 6,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-020165 · form4.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,001

Underlying: Class A Common Stock · 6,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
July 01, 2024 Filed Jul 5, 2024 20:02 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 23,496 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-020165 · form4.xml · derivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 798,873

Underlying: Class A Common Stock · 23,496 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document
July 01, 2024 Filed Jul 5, 2024 20:02 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 6,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-020165 · form4.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 208,578

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
July 01, 2024 Filed Jul 5, 2024 20:02 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 23,496 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-020165 · form4.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 202,328

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 21:06 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 13,440 $0.55 $7,378.56
Disclosure

SEC source: 0001127602-24-017961 · form4.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,832

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
May 31, 2024 Filed Jun 5, 2024 21:06 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 6,249 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-017961 · form4.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 281,251

Underlying: Class A Common Stock · 6,249 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 5, 2024 21:06 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 23,496 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-017961 · form4.xml · derivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 822,369

Underlying: Class A Common Stock · 23,496 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 5, 2024 21:06 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 6,249 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-017961 · form4.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,272

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
May 31, 2024 Filed Jun 5, 2024 21:06 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 23,496 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-017961 · form4.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,023

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
May 02, 2024 Filed May 6, 2024 20:53 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 SaleClass A Common Stock 131,928 $0.85 $111,479.16
Disclosure

SEC source: 0001127602-24-014296 · form4.xml · nonDerivative · entry 3

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,527

F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Read SEC document
May 01, 2024 Filed May 6, 2024 20:53 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 12,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-014296 · form4.xml · derivative · entry 5

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,500

Underlying: Class A Common Stock · 12,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
May 01, 2024 Filed May 6, 2024 20:53 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionRestricted Stock Units · Derivative 281,955 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-014296 · form4.xml · derivative · entry 4

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 845,865

Underlying: Class A Common Stock · 281,955 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document
May 01, 2024 Filed May 6, 2024 20:53 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 12,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-014296 · form4.xml · nonDerivative · entry 2

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 294,455

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
May 01, 2024 Filed May 6, 2024 20:53 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 Exercise / conversionClass A Common Stock 281,955 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-014296 · form4.xml · nonDerivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 281,955

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
March 07, 2024 Filed Mar 8, 2024 21:56 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 GrantRestricted Stock Units · Derivative 300,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-24-009217 · form4.xml · derivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Class A Common Stock · 300,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares on May 1, 2024, then 46 equal monthly installments thereafter.

F2 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares on May 1, 2024, then 46 equal monthly installments thereafter.

Read SEC document
July 28, 2023 Filed Jul 28, 2023 21:08 UTC Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 GrantRestricted Stock Units · Derivative 1,127,820 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021537 · form4.xml · derivative · entry 1

Coen Steven P. · CIK 0001977441 · See remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,127,820

Underlying: Class A Common Stock · 1,127,820 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares on May 1, 2024, then 36 equal monthly installments thereafter.

F2 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares on May 1, 2024, then 36 equal monthly installments thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.